Total Payments
$714.60
2020 Payments
$19.08
Companies
11
Transactions
49
Medicare Patients
3,411
Medicare Billing
$182,528
Payment Breakdown by Category
Food & Beverage$709.60 (99.3%)
Education$5.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $709.60 | 48 | 99.3% |
| Education | $5.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $189.09 | 12 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $145.49 | 10 | $0 (2017) |
| AbbVie, Inc. | $87.19 | 6 | $0 (2017) |
| Novo Nordisk Inc | $83.01 | 6 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $57.97 | 4 | $0 (2019) |
| Amgen Inc. | $47.46 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $41.34 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $24.41 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $15.89 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $12.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $19.08 | 1 | Lilly USA, LLC ($19.08) |
| 2019 | $107.02 | 7 | Lilly USA, LLC ($49.46) |
| 2018 | $73.83 | 5 | Novartis Pharmaceuticals Corporation ($42.06) |
| 2017 | $514.67 | 36 | AstraZeneca Pharmaceuticals LP ($145.49) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes | ||||||
| 09/08/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 09/06/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Neuroscience | ||||||
| 05/07/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes | ||||||
| 05/01/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
| 04/10/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 04/03/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Neuroscience | ||||||
| 01/17/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 03/14/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiology | ||||||
| 12/12/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Diabetes | ||||||
| 11/29/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 11/08/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: DIABETES | ||||||
| 11/01/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: DIABETES | ||||||
| 10/19/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Endocrinology | ||||||
| 09/26/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Diabetes | ||||||
| 09/21/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DIABETES | ||||||
| 09/14/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Endocrinology | ||||||
| 08/16/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 993 | 1,440 | $171,183 | $49,166 |
| 2022 | 12 | 1,110 | 1,891 | $178,068 | $62,702 |
| 2021 | 15 | 1,021 | 1,551 | $166,851 | $57,232 |
| 2020 | 12 | 287 | 329 | $39,567 | $13,429 |
Total Patients
3,411
Total Services
5,211
Medicare Billing
$182,528
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 284 | $68,160 | $20,657 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 112 | $25,200 | $6,175 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $16,200 | $5,860 | 36.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 77 | 77 | $18,480 | $5,516 | 29.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 84 | 84 | $6,720 | $3,375 | 50.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 72 | 144 | $7,200 | $2,323 | 32.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 63 | 63 | $5,040 | $2,181 | 43.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 69 | 70 | $11,738 | $1,456 | 12.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 42 | 43 | $2,150 | $696.60 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 41 | $1,640 | $402.87 | 24.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 11 | 11 | $1,320 | $221.85 | 16.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $1,865 | $149.38 | 8.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 51 | 55 | $1,650 | $121.00 | 7.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 40 | 382 | $3,820 | $31.51 | 0.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 236 | $56,640 | $22,264 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 119 | 119 | $35,700 | $15,002 | 42.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 212 | 216 | $17,280 | $7,544 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 100 | $22,500 | $6,914 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 65 | 65 | $15,600 | $5,653 | 36.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 88 | 180 | $9,000 | $2,940 | 32.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 42 | 42 | $5,728 | $840.10 | 14.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 37 | 37 | $1,850 | $591.56 | 32.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 75 | 77 | $3,080 | $581.60 | 18.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 20 | $1,540 | $191.86 | 12.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 55 | 58 | $1,740 | $127.03 | 7.3% |
About Dr. Gary Ross, MD
Dr. Gary Ross, MD is a Internal Medicine healthcare provider based in Lewisburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386634715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Ross, MD has received a total of $714.60 in payments from pharmaceutical and medical device companies, with $19.08 received in 2020. These payments were reported across 49 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($709.60).
As a Medicare-enrolled provider, Ross has provided services to 3,411 Medicare beneficiaries, totaling 5,211 services with total Medicare billing of $182,528. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lewisburg, WV
- Active Since 10/26/2005
- Last Updated 04/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386634715
Products in Payments
- FARXIGA (Drug) $109.42
- JARDIANCE (Drug) $98.57
- TRULICITY (Drug) $76.24
- Victoza (Drug) $53.68
- Synthroid (Drug) $45.27
- Androgel (Drug) $41.92
- AIMOVIG (Biological) $40.31
- SYMBICORT (Drug) $36.07
- Aimovig (Biological) $28.81
- SOLIQUA (Drug) $28.54
- INVOKANA (Drug) $24.41
- Repatha (Biological) $18.65
- ENTRESTO (Drug) $17.66
- Levemir (Drug) $16.49
- ADVAIR (Drug) $15.89
- BASAGLAR (Drug) $14.28
- Tresiba (Drug) $12.84
- TOUJEO (Drug) $12.80
- JANUVIA (Drug) $12.32
- LYRICA (Drug) $10.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lewisburg
Danny Cho, Md, MD
Internal Medicine — Payments: $18,942
Internal Medicine $18,942
John Weston, Md, MD
Internal Medicine — Payments: $14,377
Internal Medicine $14,377
Dr. Jillian Douglas, D.o, D.O
Internal Medicine — Payments: $3,537
Internal Medicine $3,537
Dr. Saquib Siddiqi, Do, DO
Internal Medicine — Payments: $2,873
Internal Medicine $2,873
Christopher Moll, Do, DO
Internal Medicine — Payments: $1,731
Internal Medicine $1,731
Melanie Patel, D.o, D.O
Internal Medicine — Payments: $893.71
Internal Medicine $893.71